the clinical value of cytokines measurement as tumor markers in cancer bladder

within the 5years, there have been two magor advances in the area of tumor markers, both linked to the discovery and production of monoclonal antibodies. first, several new tumor markers have been isolated that offer the potential of improved clinical usefulness in an increasing numbers of tumor type.